Ramipril: A Review of its Use in Preventing Cardiovascular Outcomes in High-Risk Patients

By Anderson Vanessa R.   Perry Caroline M.   Robinson Dean M.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 6, 2006-01 ,pp. : 417-432

Adis International

Access to resources Recommend Favorite

Spotlight on Ramipril in the Prevention of Cardiovascular Outcomes

By Warner G.T.   Perry C.M.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 2, 2003-01 ,pp. : 113-116

Adis International

Access to resources Recommend Favorite

Telmisartan: A Review of its Use in Cardiovascular Disease Prevention

By Frampton James E.  

Drugs, Vol. 71, Iss. 6, 2011-04 ,pp. : 651-677

Adis International

Access to resources Recommend Favorite

Atorvastatin: A Pharmacoeconomic Review of its Use in the Primary and Secondary Prevention of Cardiovascular Events

By Plosker Greg L.   Lyseng-Williamson Katherine A.  

PharmacoEconomics, Vol. 25, Iss. 12, 2007-01 ,pp. : 1031-1053

Adis International

Access to resources Recommend Favorite

Amlodipine/Atorvastatin Fixed-Dose Combination: A Review of its Use in the Prevention of Cardiovascular Disease and in the Treatment of Hypertension and Dyslipidemia

By McKeage Kate   Siddiqui M. Asif A.  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 1, 2008-01 ,pp. : 51-67

Adis International

Access to resources Recommend Favorite